Realbotix Corp. reported a decline in revenue for the second quarter and six-month periods ended March 31, 2026 [1].
The financial results indicate a contraction in earnings for the company, which operates across multiple exchanges including the TSX-V and OTC [1]. This downturn highlights the challenges the firm faces in maintaining its previous year's growth trajectory.
For the three-month period ending March 31, 2026, Realbotix reported revenue of $225,000 [2]. This figure represents a decrease from the $727,000 reported during the comparable three-month period in the prior fiscal year [2].
The decline continued through the first half of the year. For the six-month period ended March 31, 2026, the company generated $578,000 in revenue [2]. In the same six-month window of the previous year, the company reported revenue of $1,543,000 [2].
Realbotix, based in Las Vegas, Nevada, issued the results to provide transparency regarding its financial performance for investors and the market [1]. The company is listed under the tickers XBOT on the TSX-V, 76M0.F in Frankfurt, and XBOTF on the OTC markets [1].
The interim financial release serves as the primary disclosure for the company's fiscal health during the first two quarters of 2026 [1]. No further operational guidance was provided in the immediate financial summary [1].
“Realbotix reported revenue of $225,000 for the three-month period ended March 31, 2026.”
The substantial drop in both quarterly and semi-annual revenue suggests a period of instability or a shift in market demand for Realbotix's offerings. With revenue falling by more than 60% in the six-month comparison, the company may face pressure to adjust its business model or reduce overhead to maintain viability.
